Parallel Advisors »

Parabilis Medicines shares owned by Parallel Advisors

Quarter-by-quarter ownership of Parabilis Medicines shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Parabilis Medicines

Tip: Access up to 7 years of quarterly data

All positions including Parabilis Medicines held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Parabilis Medicines by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $15k 550 27.37

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Corcept Therapeutics Stock (CORT)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Microsoft Stock (MSFT)
Amazon.com Stock (AMZN)
Avantis International Equity Etf Etf (AVDE)
Victoryshares Free Cash Flow Etf Etf (VFLO)
Cvb Finl Corp Stock (CVBF)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Vanguard Large Cap Etf (VV)

View all positions for Parallel Advisors

Top funds holding Parabilis Medicines

Regeneron Pharmaceuticals
TD Asset Management
China Universal Asset Management
Parallel Advisors
EverSource Wealth Advisors
Efficient Wealth Management
Fifth Third Bancorp
North Star Investment Management
Bogart Wealth

View all funds holding Parabilis Medicines